Prot #PRISM-1: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma

Project: Research project

Project Details

StatusActive
Effective start/end date1/25/25 → 1/24/28

Funding

  • ICON Clinical Research, LLC (Prot# PRISM-1 // Prot# PRISM-1)
  • Arcus Biosciences, Inc (Prot# PRISM-1 // Prot# PRISM-1)